Informed Prostate Cancer Patient Support

New Evidence Shows Long-Term Survival Impact   What Prostate Cancer Patients Need to Know The Bottom Line If you're receiving hormone therapy (ADT) for prostate cancer, there's something important your doctor may not have fully explained: your testosterone may never return to normal levels after treatment ends. A major study from Princess Margaret Cancer Centre found that 6 out of 10 men treated with just six months of hormone therapy combined with radiation never recovered their testosterone levels—even after 10 years. Those who didn't recover faced twice the risk of dying compared to men whose testosterone bounced back. This wasn't just about prostate cancer—it was about heart disease, diabetes, and other health problems caused by long-term low testosterone. This matters whether you're considering hormone therapy for the first time or already receiving it. Understanding these risks should be part of every treatment decision, especially if you're younger or ...

The role of the human microbiome in prostate cancer: a systematic review from diagnosis to treatment | Prostate Cancer and Prostatic Diseases BLUF (Bottom Line Up Front): New research reveals that the trillions of bacteria living in your body—your microbiome—significantly influence prostate cancer diagnosis, progression, and treatment response. Specific bacterial signatures can predict castration resistance 5+ months earlier, while microbiome disruption during ADT may accelerate treatment failure. Though still investigational, microbiome profiling could soon personalize treatment decisions, and simple interventions like probiotics during therapy show promise for improving outcomes and reducing side effects. A Deep Dive into Emerging Research on the Bacteria Within Us For decades, we've understood prostate cancer through the lens of genetics, hormones, and cellular biology. But groundbreaking research is revealing an unexpected player in this disease: the trillions of microorga...